Canopy Biosciences
Canopy Biosciences is an emerging life science company located in the Cortex Innovation District of St. Louis, Missouri. Founded in 2016 by industry veterans in biomedical research and genetic engineering, Canopy has successfully identified cutting-edge technologies from some of the world’s most respected academic institutions and rapidly brought them to market as innovative products and services.
Charles River
Charles River applies its deep expertise and extensive capabilities in the field of neuroscience to create innovative, flexible and efficient solutions to advance neuroscience research and preclinical drug development.
Applied Biological Materials Inc.
ABM Inc. develops and commercializes research products and services for scientists around the world. Dedicated in catalyzing scientific discoveries in [...]
Applied StemCell Inc
After more than 11 years' of research and development, ASC is proud to offer an optimized series of tools for basic research study, drug discovery, bio-processing, bio-production and preclinical applications.
Atuka Inc.
Atuka provides contract research services with world-leading expertise in Parkinson's disease and related neurological conditions
Advanced Targeting Systems, Inc.
Advanced Targeting Systems, “the saporin people,” provides quality targeting reagents for the specific elimination of cells to examine the impact on behaviour and/or disease states. The product line includes targeted toxins, antibodies and custom conjugation services.
Antibodies Incorporated
Antibodies Incorporated is the commercial partner for the NIH-funded NeuroMab initiative.
Myologica
Myologica is a contract research organization specializing in neuromuscular function and muscle phenotyping. Started in collaboration with the University of Maryland, Myologica seeks to fill a void in specialized muscle function testing and help others with their research.
Crown Bioscience
Find out how Crown Bioscience is advancing drug development and cancer research in our webinars, articles, and interviews.
